国泰海通证券股份有限公司 关于深圳中科飞测科技股份有限公司使用部分闲置募集资 金及自有资金进行现金管理的核查意见 国泰海通证券股份有限公司（以下简称"国泰海通"、"保荐人"）作为深圳 中科飞测科技股份有限公司（以下简称"中科飞测"或"公司"）首次公开发行 股票并在科创板上市的持续督导机构，根据《上市公司监管指引第 2 号——上市 公司募集资金管理和使用的监管要求》《上海证券交易所科创板上市公司自律监 管指引第 1 号——规范运作》等有关规定，对中科飞测拟使用部分闲置募集资金 （含超募资金）及自有资金进行现金管理的事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会核发的《关于同意深圳中科飞测科技股份有限 公司首次公开发行股票注册的批复》（证监许可[2023]367 号），公司于 2023 年 5 月 19 日首次公开发行人民币普通股（A 股）股票 80,000,000 股，发行价格为人 民币 23.60 元/股，募集资金总额为人民币 188,800.00 万元，扣除各项不含税发行 费用人民币 18,961.34 万元后，实际募集资金净额为人民币 169,838.66 万元。 （ ...

Financial Performance - The company achieved operating revenue of CNY 294,158,044.69, representing a year-on-year increase of 24.89%[4] - The net profit attributable to shareholders was CNY -14,960,459.19, a decrease of 143.69% compared to the same period last year[4] - The basic earnings per share were CNY -0.05, down 145.45% from CNY 0.11 in the same period last year[4] - The company reported a gross profit margin decline, with gross profit for Q1 2025 at ¥170,835,795.12, down from ¥123,124,664.91 in Q1 2024, reflecting challenges in cost management[19] - In Q1 2025, the company reported a net profit of -14,960,459.19 RMB, a significant decrease compared to a net profit of 34,240,129.57 RMB in Q1 2024, representing a decline of approximately 143.6%[20] - The company recorded a total comprehensive income of -7,469,660.47 RMB in Q1 2025, down from 34,133,859.26 RMB in Q1 2024, a decline of approximately 121.9%[21] Research and Development - Research and development expenses totaled CNY 120,354,159.82, an increase of 64.00% year-on-year, accounting for 40.91% of operating revenue[5] - The company plans to continue increasing R&D investment to break the monopoly of foreign companies in the domestic market[6] - Research and development expenses rose to 120,354,159.82 RMB in Q1 2025, up from 73,385,874.08 RMB in Q1 2024, an increase of about 64.0%[20] Assets and Liabilities - The total assets of the company increased by 7.27% to CNY 4,514,020,237.88 compared to the end of the previous year[5] - Current assets totaled ¥3,261,910,739.82 as of March 31, 2025, compared to ¥3,047,446,136.88 at the end of 2024, indicating a growth of approximately 7%[16] - Non-current assets increased to ¥1,252,109,498.06 as of March 31, 2025, from ¥1,160,511,277.03 at the end of 2024, representing a growth of about 7.9%[16] - Total liabilities reached ¥2,056,364,079.81 as of March 31, 2025, compared to ¥1,770,346,768.59 at the end of 2024, representing an increase of about 16.2%[17] - Current liabilities rose to ¥1,556,689,626.08 as of March 31, 2025, from ¥1,403,074,582.74 at the end of 2024, reflecting an increase of about 10.9%[16] - Long-term borrowings increased significantly to ¥249,064,000.00 as of March 31, 2025, compared to ¥130,864,000.00 at the end of 2024, indicating a growth of approximately 90%[16] Shareholder Information - Total number of common shareholders at the end of the reporting period is 11,086[11] - The largest shareholder, Suzhou Yiliu Mingguang Technology Co., Ltd., holds 37,800,963 shares, accounting for 11.81% of total shares[11] - The second-largest shareholder, Guotou (Shanghai) Investment Management Co., Ltd., holds 30,259,767 shares, representing 9.46%[11] - The company has a total of 8,337,799 shares held by Guangdong Hongtu Investment Management Co., Ltd., accounting for 2.61%[12] - The top ten shareholders collectively hold significant stakes, with the largest three shareholders alone accounting for over 26% of total shares[11] Cash Flow and Expenses - The net cash flow from operating activities was CNY -48,745,457.34, reflecting increased expenditures due to business scale growth[4][6] - Cash and cash equivalents at the end of Q1 2025 were 433,390,183.42 RMB, down from 603,551,708.99 RMB at the end of Q1 2024, a decrease of about 28.2%[23] - The company incurred financial expenses of 4,817,492.83 RMB in Q1 2025, compared to -2,932,306.38 RMB in Q1 2024, indicating a shift from income to expense in financial activities[20] - The company's investment activities resulted in a net cash outflow of -285,559,984.38 RMB in Q1 2025, contrasting with a net inflow of 270,587,671.62 RMB in Q1 2024, highlighting a significant change in investment strategy[23] Operational Strategy - The company is focusing on high-end semiconductor quality control, with ongoing progress in new product validation and upgrades[6] - The company is implementing a stock incentive plan to stabilize its core talent team, leading to increased share-based payment expenses[6] - The company is actively involved in various investment partnerships, indicating a strategy focused on collaborative growth and capital management[13] Audit and Compliance - The financial statements for the quarter have not been audited, indicating a potential area for investor scrutiny[14] - There are no applicable reminders for investors regarding the company's operational situation during the reporting period[14] - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending activities[13]

Financial Performance - The company reported a basic earnings per share of -0.0500 yuan for Q1 2025, a decrease of 145.45% compared to 0.1100 yuan in Q1 2024 [1] - Net profit for Q1 2025 was -0.15 billion yuan, down 144.12% from 0.34 billion yuan in Q1 2024 [1] - Operating revenue increased by 24.58% to 2.94 billion yuan in Q1 2025, compared to 2.36 billion yuan in Q1 2024 [1] - The return on equity (ROE) was -0.61% in Q1 2025, a significant decline from 1.41% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 10,731.62 million shares, accounting for 43.94% of the circulating shares, with a decrease of 617.16 million shares compared to the previous period [2] - The largest shareholder, Guotou (Shanghai) Venture Capital Management Co., Ltd., holds 3,025.98 million shares, representing 12.39% of total shares, with a reduction of 395.12 million shares [3] - China Life Insurance Company holds 527.63 million shares, which is 2.16% of total shares, with an increase of 67.24 million shares [3] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [4]

证券代码：688361 证券简称：中科飞测 公告编号：2025-031 深圳中科飞测科技股份有限公司 关于 2025 年第一季度计提资产减值准备的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、 计提减值准备的情况概述 | 项目 | 2025 | 年 1-3 | 月计提金额 | 备注 | | --- | --- | --- | --- | --- | | 信用减值损失 | | | 963,058.55 | 应收账款及其他应收款坏账损失、应 收款项融资减值损失 | | 资产减值损失 | | | -15,904,263.82 | 存货跌价损失、合同资产减值损失 | | 合计 | | | -14,941,205.27 | | 二、 计提减值准备事项的具体说明 （一） 信用减值损失 公司以预期信用损失为基础，对应收账款、其他应收款及应收款项融资进行 了减值测试。经测试，本次需冲减信用减值损失金额共计963,058.55元。 （二） 资产减值损失 公司以预期信用损失为基础，对合同资产进行了减值测试。对存货资产，在 资产负债 ...

证券代码：688361 证券简称：中科飞测 公告编号：2025-030 深圳中科飞测科技股份有限公司 关于使用部分闲置募集资金及自有资金 进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳中科飞测科技股份有限公司（以下简称"公司"）于 2025 年 4 月 25 日分 别召开了第二届董事会第十三次会议和第二届监事会第十三次会议，分别审议通 过了《关于使用部分闲置募集资金（含超募资金）及自有资金进行现金管理的议 案》，同意公司使用不超过人民币 30,000 万元（含本数）的闲置募集资金（含 超募资金）和不超过人民币 100,000 万元的自有资金（含本数）进行现金管理， 使用期限自上一次授权期限到期日（2025 年 6 月 4 日）后 12 个月内有效，在上 述额度和期限内，资金可循环滚动使用。现将具体情况公告如下： 一、 募集资金基本情况 根据中国证券监督管理委员会核发的《关于同意深圳中科飞测科技股份有限 公司首次公开发行股票注册的批复》（证监许可[2023]367 号），公司于 2023 年 5 月 ...

证券代码：688361 证券简称：中科飞测 公告编号：2025-028 深圳中科飞测科技股份有限公司 关于召开 2024 年度暨 2025 年第一季度 业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： （二）会议召开地点：上证路演中心 （三）会议召开方式：上证路演中心网络互动 会议召开时间：2025 年 5 月 7 日（星期三）15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2025 年 4 月 25 日（星期五）至 5 月 6 日（星期二）16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 IR@skyverse.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 深圳中科飞测科技股份有限公司（以下简称"公司"）已于 2025 年 4 月 4 日发布公司 2024 年年度 ...

国泰海通证券股份有限公司 关于深圳中科飞测科技股份有限公司 2024 年度持续督导跟踪报告 国泰海通证券股份有限公司（以下简称"国泰海通"）作为深圳中科飞测科 技股份有限公司（以下简称"中科飞测"或"公司"）首次公开发行股票并在科 创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上海证券交易所 科创板股票上市规则》《上海证券交易所上市公司持续督导工作指引》等相关规 定，作为公司持续督导工作的保荐人，负责中科飞测上市后的持续督导工作，并 出具本持续督导跟踪报告。 | 序号 | 工作内容 | 持续督导情况 | | --- | --- | --- | | 1 | 建立健全并有效执行持续督导工作制度，并针对具 | 保荐机构已根据持续督导工 | | | 体的持续督导工作制定相应的工作计划 | 作进度制定相应工作计划 | | 2 | 根据中国证监会相关规定，在持续督导工作开始 前，与上市公司或相关当事人签署持续督导协议， 明确双方在持续督导期间的权利义务，并报上海证 | | | | | 保荐机构已与中科飞测签署 | | | | 协议，明确了双方在持续督 | | | | 导期间的权利义务 | | | 券交易所备案 ...

Core Points - The company announced the decision to cancel a total of 237,387 restricted stocks that were granted but not vested due to various reasons, including one employee's departure and performance evaluations not meeting the required standards [2][21][22] Group 1: Board Meeting Decisions - The second board meeting of the company was held on April 15, 2025, with all nine directors present, and the meeting was deemed legal and effective [1] - The board approved the proposal to cancel 22,262 shares of restricted stock due to one grantee's departure and a total of 215,125 shares due to unsatisfactory personal performance evaluations [19][20] - The total number of restricted stocks canceled amounts to 237,387 shares [21] Group 2: Performance Evaluation and Vesting Conditions - The company achieved a 100% vesting ratio at the company level for the first vesting period, but individual performance evaluations resulted in varying vesting ratios: 85% for seven individuals rated "Excellent (A)", 70% for four rated "Excellent (A-)", 50% for four rated "Good (B)", and 0% for five rated "Average (C)" [20] - The board also approved the achievement of vesting conditions for 1,591,809 shares for 107 eligible grantees based on the performance evaluation results [5][40] Group 3: Legal and Compliance - The company has complied with all necessary legal and regulatory requirements regarding the cancellation and vesting of restricted stocks, as confirmed by the legal opinion from Beijing Junhe Law Firm [24][47] - The monitoring committee has verified that the cancellation of the restricted stocks does not harm the interests of the company or its shareholders, particularly minority shareholders [23][9]

深圳中科飞测科技股份有限公司 第二届监事会第十二次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 深圳中科飞测科技股份有限公司（以下简称"公司"）第二届监事会第十 二次会议于 2025 年 4 月 15 日以通讯方式在公司会议室召开，会议通知于 2025 年 4 月 11 日以电子邮件方式送达至全体监事。本次会议应到监事 3 人，实到监 事 3 人，会议由监事会主席陈彬女士召集并主持。会议的召集和召开程序符合《中 华人民共和国公司法》和《深圳中科飞测科技股份有限公司章程》等相关规定， 会议形成的决议合法、有效。 二、监事会会议审议情况 （一）审议通过《关于作废部分已授予尚未归属的限制性股票的议案》 证券代码：688361 证券简称：中科飞测 公告编号：2025-025 公司监事会认为：本次作废 2024 年限制性股票激励计划部分已授予尚未归 属的限制性股票符合《上市公司股权激励管理办法》（以下简称"《管理办法》"） 和公司《2024 年限制性股票激励计划（草案）》（以下简称"《激励计划 ...

经各位董事认真审议，会议形成了如下决议： （一）审议通过《关于作废部分已授予尚未归属的限制性股票的议案》 证券代码：688361 证券简称：中科飞测 公告编号：2025-024 深圳中科飞测科技股份有限公司 第二届董事会第十二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、董事会会议召开情况 深圳中科飞测科技股份有限公司（以下简称"公司"）第二届董事会第十二 次会议于 2025 年 4 月 15 日以通讯方式在公司会议室召开，会议通知于 2025 年 4 月 11 日以电子邮件方式送达至各位董事。本次会议应到董事 9 人，实到董事 9 人。会议由陈鲁先生主持，会议的召集和召开程序符合《中华人民共和国公司法》 和《深圳中科飞测科技股份有限公司章程》等相关规定，会议形成的决议合法、 有效。 二、董事会会议审议情况 根据《2024 年限制性股票激励计划实施考核管理办法》《上海证券交易所 科创板股票上市规则》《2024 年限制性股票激励计划（草案）》及其摘要的相 关规定，由于本次激励计划首次授予部分激励对象中 ...